Hirsh, V., Melosky, B., Goss, G., Morris, D., & Morzycki, W. (2012). Corrigendum: A personalized approach to treatment: use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada. Multimed Inc.
Citación estilo ChicagoHirsh, V., B. Melosky, G. Goss, D. Morris, and W. Morzycki. Corrigendum: A Personalized Approach to Treatment: Use of Egfr Tyrosine Kinase Inhibitors for the Treatment of Non-small-cell Lung Cancer in Canada. Multimed Inc, 2012.
Cita MLAHirsh, V., et al. Corrigendum: A Personalized Approach to Treatment: Use of Egfr Tyrosine Kinase Inhibitors for the Treatment of Non-small-cell Lung Cancer in Canada. Multimed Inc, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.